EMD Serono, Inc.
Pharmaceutical ManufacturingMassachusetts, United States1001-5000 Employees
EMD Serono, Inc. operates as the U.S. and Canada healthcare business of Merck KGaA, Darmstadt, Germany, within the pharmaceutical manufacturing sector. The company develops and delivers therapies for infertility, multiple sclerosis and cancer, with the aim of improving and prolonging the lives of people affected by these conditions. Reflecting its global roots of more than 350 years, the organization maintains commercial, clinical and research activities in Massachusetts and employs roughly 1,100 people across the United States. Headquartered in Boston, Massachusetts, the firm positions itself within the pharmaceutical industry as a translational science-focused operator seeking to convert molecular discoveries into meaningful patient outcomes for unmet medical needs. In 2025, it launched a direct-to-consumer program, illustrating a concrete development in its portfolio activities. As part of Merck KGaA, the company maintains its U.S. and Canada focus as a component of a long-established global enterprise.